Vaccines, coming of age after 200 years.
An overview on the short, only 200 years, past history and future expectations in the field of vaccines is presented. The focus is on development trends and potential rather than individual vaccines. While the first vaccines were a result of keen observation, the further development has been tightly dependent on the development of microbiology to provide both the knowledge basis and the technology for new vaccines for new purposes. The post-genomic era just starting therefore promises an exponential increase of vaccine research and new vaccines, both improved vaccines with a greater efficacy and less adverse effects to replace old ones and vaccines for prevention of diseases for which no vaccines exist. Furthermore, fully new applications to prevention or treatment of chronic diseases not traditionally associated with infections are expected.
Mäkelä
P H
PH
National Public Health Institute, Mannerheimintie 166, FIN-00300, Helsinki, Finland.
D019496:Cancer Vaccines; D049671:History, 18th Century; D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D007115:Immunization Schedule; D014611:Vaccination / Q000266:history / Q000639:trends*; D014612:Vaccines / Q000266:history*; D014613:Vaccines, Attenuated / Q000235:genetics; D018074:Vaccines, Conjugate; D019444:Vaccines, DNA; D014614:Vaccines, Synthetic
D019496:Cancer Vaccines; D014612:Vaccines; D014613:Vaccines, Attenuated; D018074:Vaccines, Conjugate; D019444:Vaccines, DNA; D014614:Vaccines, Synthetic